Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
August 7, 2021
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
Robin Reschke, Philipp Gussek, Andreas Boldt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 12, 2024
Pediatric cancer patients vaccinated against SARS-CoV-2-a clinical and laboratory follow-up
Benjamin Siebald, Andreas H Groll, Sarah Salou, et al.
Scientific Reports
|
December 6, 2016
Ascites' neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation
Cornelius Engelmann, Christina Becker, Andreas Boldt, et al.
Annals of the Rheumatic Diseases
|
May 30, 2025
Effective use of anti-CD19 chimeric antigen receptor T cells in a case of treatment-resistant granulomatosis with polyangiitis
Luisa Uhlmann, Matthias Pierer, Marco Krasselt, et al.
Frontiers in Immunology
|
May 20, 2021
Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications
Ulrich Blache, Ronald Weiss, Andreas Boldt, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 26, 2016
Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells
Nadja Hilger, Jakob Glaser, Claudia Müller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 28, 2022
Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, et al.
Blood Advances
|
April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cells
Bettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Allergy
|
January 31, 2025
Dichotomous STAT5 and STAT6 Activation in T Cells Reflects Cytokine Shifts Between Blood and Skin in Atopic Dermatitis
Andreas Boldt, Regina Treudler, Marie Rabe, et al.
Hemasphere
|
June 16, 2025
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma
Patrick Born, David Fandrei, Song Yau Wang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
August 7, 2021
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
Robin Reschke, Philipp Gussek, Andreas Boldt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 12, 2024
Pediatric cancer patients vaccinated against SARS-CoV-2-a clinical and laboratory follow-up
Benjamin Siebald, Andreas H Groll, Sarah Salou, et al.
Scientific Reports
|
December 6, 2016
Ascites' neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation
Cornelius Engelmann, Christina Becker, Andreas Boldt, et al.
Annals of the Rheumatic Diseases
|
May 30, 2025
Effective use of anti-CD19 chimeric antigen receptor T cells in a case of treatment-resistant granulomatosis with polyangiitis
Luisa Uhlmann, Matthias Pierer, Marco Krasselt, et al.
Frontiers in Immunology
|
May 20, 2021
Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications
Ulrich Blache, Ronald Weiss, Andreas Boldt, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
August 26, 2016
Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells
Nadja Hilger, Jakob Glaser, Claudia Müller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 28, 2022
Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, et al.
Blood Advances
|
April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cells
Bettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Allergy
|
January 31, 2025
Dichotomous STAT5 and STAT6 Activation in T Cells Reflects Cytokine Shifts Between Blood and Skin in Atopic Dermatitis
Andreas Boldt, Regina Treudler, Marie Rabe, et al.
Hemasphere
|
June 16, 2025
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma
Patrick Born, David Fandrei, Song Yau Wang, et al.
Page
of 6